Elevated serum IgG4 defines specific clinical phenotype of rheumatoid arthritis

Mediators of Inflammation

Volumn 2014, Issue , 2014, Pages

  Chen, Le Feng ^a   Mo, Ying Qian ^a   Ma, Jian Da ^a   Luo, Ling ^a   Zheng, Dong Hui ^a   Dai, Lie ^a  

^a SUN YAT SEN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CD20 ANTIGEN; CD3 ANTIGEN; CD38 ANTIGEN; CYCLIC CITRULLINATED PEPTIDE ANTIBODY; IMMUNOGLOBULIN G4; LEFLUNOMIDE; METHOTREXATE; RHEUMATOID FACTOR; AUTOANTIBODY; CYCLIC CITRULLINATED PEPTIDE; CYCLOPEPTIDE; IMMUNOGLOBULIN G;

ADULT; AGED; ARTICLE; CELL COUNT; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ACTIVITY; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; PLASMA CELL; RHEUMATOID ARTHRITIS; SYNOVITIS; SYNOVIUM; TREATMENT RESPONSE; VERY ELDERLY; BIOPSY; BLOOD; METABOLISM; MIDDLE AGED; SYNOVIAL FLUID; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD20; ANTIGENS, CD3; ANTIGENS, CD38; ARTHRITIS, RHEUMATOID; AUTOANTIBODIES; BIOPSY; BLOOD SEDIMENTATION; C-REACTIVE PROTEIN; FEMALE; HUMANS; IMMUNOGLOBULIN G; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; PEPTIDES, CYCLIC; PHENOTYPE; RHEUMATOID FACTOR; SYNOVIAL FLUID; SYNOVITIS; YOUNG ADULT;

EID: 84919775663     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2014/635293     Document Type: Article

References (44)

1. M. A. van der Helm-van, K. N. Verpoort, F. C. Breedveld et al., "Antibodies to citrullinated proteins and differences in clinical progression of rheumatoid arthritis," Arthritis Research &Therapy, vol. 7, no. 5, pp. R949-R958, 2005
2. M. Z. Cader, A. D. Filer, C. D. Buckley, and K. Raza, "The relationship between the presence of anti-cyclic citrullinated peptide antibodies and clinical phenotype in very early rheumatoid arthritis,"BMCMusculoskeletal Disorders, vol. 11, article 187, 2010
3. M. Mullazehi, L. Mathsson, J. Lampa, and J. Rönnelid, "High anti-collagen type-II antibody levels and induction of proinflammatory cytokines by anti-collagen antibody-containing immune complexes in vitro characterise a distinct rheumatoid arthritis phenotype associated with acute inflammation at the time of disease onset," Annals of the Rheumatic Diseases, vol. 66, no. 4, pp. 537-541, 2007
4. H. Umehara, K. Okazaki, Y. Masaki et al., "Comprehensive diagnostic criteria for IgG4-related disease (IgG4-RD), 2011," Modern Rheumatology, vol. 22, no. 1, pp. 21-30, 2012
5. M. Yamamoto, M. Ohara, C. Suzuki et al., "Elevated IgG4 concentrations in serum of patients with Mikulicz's disease," Scandinavian Journal of Rheumatology, vol. 33, no. 6, pp. 432-433, 2004
6. H. Hamano, S. Kawa, A. Horiuchi et al., "High serum IgG4 concentrations in patients with sclerosing pancreatitis," The New England Journal of Medicine, vol. 344, no. 10, pp. 732-738, 2001
7. G. Lin and J. Li, "Elevation of serumIgG subclass concentration in patients with rheumatoid arthritis," Rheumatology International, vol. 30, no. 6, pp. 837-840, 2010
8. M. Yamamoto, T. Tabeya, Y. Naishiro et al., "Value of serum IgG4 in the diagnosis of IgG4-related disease and in differentiation from rheumatic diseases and other diseases," Modern Rheumatology/The Japan Rheumatism Association, vol. 22, no. 3, pp. 419-425, 2012
9. D. T. Felson, J. J. Anderson, M. Boers et al., "The American College ofRheumatology preliminary core set of disease activity measures for rheumatoid arthritis clinical trials," Arthritis and Rheumatism, vol. 36, no. 6, pp. 729-740, 1993
10. D. Gerlag and P. P. Tak, "Synovial biopsy," Best Practice & Research: Clinical Rheumatology, vol. 19, no. 3, pp. 387-400, 2005
11. Y.-Q. Mo, L. Dai, D.-H. Zheng et al., "Synovial infiltration with CD79a-positive B cells, but not other B cell lineage markers, correlates with joint destruction in rheumatoid arthritis," The Journal of Rheumatology, vol. 38, no. 11, pp. 2301-2308, 2011
12. V. Krenn, L. Morawietz, G.-R. Burmester et al., "Synovitis score: discrimination between chronic low-grade and highgrade synovitis," Histopathology, vol. 49, no. 4, pp. 358-364, 2006
13. Y. Masaki, N. Kurose, M. Yamamoto et al., "Cutoff values of serum IgG4 and histopathological IgG4+ plasma cells for diagnosis of patients with IgG4-related disease," International Journal of Rheumatology, vol. 2012, Article ID 580814, 5 pages, 2012
14. A. Aceti, A. Pennica, A. Teggi et al., "IgG subclasses in human hydatid disease: prominence of the IgG4 response," International Archives of Allergy and Immunology, vol. 102, no. 4, pp. 347-351, 1993
15. T. Funakoshi, L. Lunardon, C. T. Ellebrecht, A. R. Nagler, C. E. O'Leary, and A. S. Payne, "Enrichment of total serum IgG4 in patients with pemphigus," The British Journal of Dermatology, vol. 167, no. 6, pp. 1245-1253, 2012
16. Y. Sato, M. Kojima, K. Takata et al., "Multicentric Castleman's disease with abundant IgG4-positive cells: a clinical and pathological analysis of six cases," The Journal of Clinical Pathology, vol. 63, no. 12, pp. 1084-1089, 2010
17. H. Kimata, I. Lindley, and K. Furusho, "Selective inhibition of spontaneous IgE and IgG4 production by interleukin-8 in atopic patients," Blood, vol. 85, no. 11, pp. 3191-3198, 1995
18. H. Kimata, A. Yoshida, C. Ishioka, M. Fujimoto, I. Lindley, and K. Furusho, "RANTES and macrophage inflammatory protein 1 selectively enhance immunoglobulin (IgE) and IgG4 production by human B cells," The Journal of Experimental Medicine, vol. 183, no. 5, pp. 2397-2402, 1996
19. H. Kimata,M. Fujimoto, C. Ishioka, and A. Yoshida, "Histamine selectively enhances human immunoglobulin E (IgE) and IgG4 production induced by anti-CD58 monoclonal antibody," The Journal of Experimental Medicine, vol. 184, no. 2, pp. 357-364, 1996
20. Y. Zen, T. Fujii, K. Harada et al., "Th2 and regulatory immune reactions are increased in immunoglobin G4-related sclerosing pancreatitis and cholangitis," Hepatology, vol. 45, no. 6, pp. 1538-1546, 2007
21. H. Nakashima, K. Miyake, M. Moriyama et al., "An amplification of IL-10 and TGF-beta in patients with IgG4-related tubulointerstitial nephritis," Clinical Nephrology, vol. 73, no. 5, pp. 385-391, 2010
22. M. R. Hussein, N. A. Fathi, A. M. E. El-Din et al., "Alterations of the CD4+, CD8+ T cell subsets, interleukins-1, IL-10, IL-17, tumor necrosis factor and soluble intercellular adhesion molecule-1 in rheumatoid arthritis and osteoarthritis: Preliminary observations," Pathology and Oncology Research, vol. 14, no. 3, pp. 321-328, 2008
23. O. Dienz, S. M. Eaton, J. P. Bond et al., "The induction of antibody production by IL-6 is indirectly mediated by IL-21 produced by CD4+ T cells," The Journal of Experimental Medicine, vol. 206, no. 1, pp. 69-78, 2009
24. R. Ettinger, G. P. Sims, A.-M. Fairhurst et al., "IL-21 induces differentiation of human naive and memory B cells into antibodysecreting plasma cells,"The Journal of Immunology, vol. 175, no. 12, pp. 7867-7879, 2005
25. T. Robak, A. Gladalska, H. Stepień, and E. Robak, "Serum levels of interleukin-6 type cytokines and soluble interleukin-6 receptor in patients with rheumatoid arthritis," Mediators of Inflammation, vol. 7, no. 5, pp. 347-353, 1998
26. F. A. Houssiau, J.-P. Devogelaer, J. van Damme, C. Nagant de Deuxchaisnes, and J. van Snick, "Interleukin-6 in synovial fluid and serum of patients with rheumatoid arthritis and other inflammatory arthritides,"Arthritis and Rheumatism, vol. 31,no. 6, pp. 784-788, 1988
27. Y. Masaki, L. Dong, N. Kurose et al., "Proposal for a new clinical entity, IgG4-positive multiorgan lymphoproliferative syndrome: analysis of 64 cases of IgG4-related disorders," Annals of the Rheumatic Diseases, vol. 68, no. 8, pp. 1310-1315, 2009
28. Y. Sato, M. Kojima, K. Takata et al., "Systemic IgG4-related lymphadenopathy: a clinical and pathologic comparison to multicentric Castleman's disease," Modern Pathology, vol. 22, no. 4, pp. 589-599, 2009
29. N. Nishimoto and T. Kishimoto, "Interleukin 6: from bench to bedside," Nature Clinical Practice Rheumatology, vol. 2, no. 11, pp. 619-626, 2006
30. G. Carbone, A. Wilson, S. A. Diehl, J. Bunn, S. M. Cooper, and M. Rincon, "Interleukin-6 receptor blockade selectively reduces IL-21 production by CD4 T cells and IgG4 autoantibodies in rheumatoid arthritis," International Journal of Biological Sciences, vol. 9, no. 3, pp. 279-288, 2013
31. M. N. Carruthers, A. Khosroshahi, T. Augustin, V. Deshpande, and J. H. Stone, "The diagnostic utility of serum IgG4 concentrations in IgG4-related disease," Annals of the Rheumatic Diseases, vol. 2014,Article ID 204907, 5 pages, 2014
32. S. Kawa, T. Ito, T. Watanabe et al., "The utility of serum IgG4 concentrations as a biomarker," International Journal of Rheumatology, vol. 2012,Article ID 198314, 4 pages, 2012
33. P. L. Cohen, R. L. Cheek, J. A. Hadler, W. J. Yount, and R. A. Eisenberg, "The subclass distribution of human IgGrheumatoid factor,"TheJournal of Immunology, vol. 139, no. 5,pp. 1466-1471, 1987
34. R. Engelmann, J. Brandt, M. Eggert et al., "IgG1 and IgG4 are the predominant subclasses among auto-antibodies against two citrullinated antigens in RA," Rheumatology, vol. 47, no. 10, pp. 1489-1492, 2008
35. W. H. Bos, G. M. Bartelds, M. Vis et al., "Preferential decrease in IgG4 anti-citrullinated protein antibodies during treatment with tumour necrosis factor blocking agents in patients with rheumatoid arthritis," Annals of the Rheumatic Diseases, vol. 68, no. 4, pp. 558-563, 2009
36. H. Hamano, S. Kawa, A. Horiuchi et al., "High serum IgG4 concentrations in patients with sclerosing pancreatitis," The New England Journal of Medicine, vol. 344, no. 10, pp. 732-738, 2001
37. S. Kawa and H. Hamano, "Clinical features of autoimmune pancreatitis," Journal of Gastroenterology, vol. 42, no. 18, pp. 9-14, 2007
38. L. Frulloni and C. Lunardi, "Serum IgG4 in autoimmune pancreatitis: a marker of disease severity and recurrence" Digestive and Liver Disease, vol. 43, no. 9, pp. 674-675, 2011
39. V. Deshpande, Y. Zen, J. K. C. Chan et al., "Consensus statement on the pathology of IgG4-related disease," Modern Pathology, vol. 25, no. 9, pp. 1181-1192, 2012
40. Z. Szekanecz, G. K. Haines, L. A. Harlow et al., "Increased synovial expression of transforming growth factor (TGF) receptor endoglin and TGF 1 in rheumatoid arthritis: possible interactions in the pathogenesis of the disease," Clinical Immunology and Immunopathology, vol. 76, no. 2, pp. 187-194, 1995
41. M. V. D. N. Kolfschoten, J. Schuurman, M. Losen et al., "Antiinflammatory activity of human IgG4 antibodies by dynamic Fab arm exchange," Science, vol. 317, no. 5844, pp. 1554-1557, 2007
42. S. Kawa, K. Kitahara, H. Hamano et al., "Anovel immunoglobulin-immunoglobulin interaction in autoimmunity," PLoS ONE, vol. 3, no. 2, Article ID e1637, 2008
43. B. Rock, C. R. Martins, A. N. Theofilopoulos et al., "The pathogenic effect of IgG4 autoantibodies in endemic pemphigus foliaceus (fogo selvagem)," The New England Journal of Medicine, vol. 320, no. 22, pp. 1463-1469, 1989
44. S. J. Warren, L. A. Arteaga, E. A. Rivitti et al., "The role of subclass switching in the pathogenesis of endemic pemphigus foliaceus," Journal of Investigative Dermatology, vol. 120, no. 1, pp. 104-108, 2003.